Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Business & Industry
- GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment, sotrovimab
- Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people
- Pfizer and BioNTech to provide U.S. government with an additional 200 million doses of COVID-19 vaccine
- AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
- Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19
Research & Development
- Thinking impaired in 60% of COVID-19 survivors
- Advantages of intranasal vaccination against SARS-CoV-2
- Antibiotics may help to treat melanoma
- Take your best shot: Which SARS-CoV-2 vaccine should I get, if any?
- Study shows why second dose of COVID-19 vaccine shouldn't be skipped
- Are silver nanoparticles a silver bullet against microbes?
- One shot of the Sputnik V vaccine triggers strong antibody responses
Conferences & Events
- Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry
- Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
Regulatory Affairs
- FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
- FDA approves first oral blood thinning medication for children
- FDA grants accelerated approval for Alzheimer's drug
- FDA approves new drug treatment for chronic weight management, first since 2014
- FDA authorizes additional monoclonal antibody for treatment of COVID-19